Most Pennsylvania medical malpractice cases involving cancer focus on delayed or missed diagnoses - situations where cancer is present, but doctors fail to detect it in time. This Philadelphia case illustrates a less common, yet equally devastating error: diagnosing cancer that never existed and subjecting a patient to irreversible treatment.

This article explores how emerging gene-editing technologies like CRISPR may help prevent strokes and cancer in genetically predisposed individuals, especially in light of frequent Philadelphia stroke misdiagnosis and cancer mistreatment cases.